Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kay-Uwe Wagner

Showing results (61-70 of 124) with videos related to

Pageof 13
Sort By:
The Journal of Biological Chemistry|March 9, 2002
Loss of the peroxisome proliferation-activated receptor gamma (PPARgamma ) does not affect mammary development and propensity for tumor formation but leads to reduced fertilityYongzhi Cui, Keiko Miyoshi, Estefania Claudio, et al.
Biology of Reproduction|January 24, 2002
Bcl-x is not required for maintenance of follicles and corpus luteum in the postnatal mouse ovaryGregory Riedlinger, Ryugo Okagaki, Kay-Uwe Wagner, et al.
The American Journal of Pathology|June 11, 2013
Loss of Jak2 impairs endothelial function by attenuating Raf-1/MEK1/Sp-1 signaling along with altered eNOS activitiesPing Yang, Yawen Zhang, Junfeng Pang, et al.
Molecular Endocrinology (Baltimore, Md.)|June 7, 2007
Coactivation of janus tyrosine kinase (Jak)1 positively modulates prolactin-Jak2 signaling in breast cancer: recruitment of ERK and signal transducer and activator of transcription (Stat)3 and enhancement of Akt and Stat5a/b pathwaysLynn M Neilson, Jianquong Zhu, Jianwu Xie, et al.
Cell Cycle (Georgetown, Tex.)|October 20, 2004
Brca1-deficient murine mammary epithelial cells have increased sensitivity to CDDP and MMSMagdalene K Sgagias, Kay-Uwe Wagner, Brad Hamik, et al.
Cancer Research|March 18, 2004
Brca2 deficiency does not impair mammary epithelium development but promotes mammary adenocarcinoma formation in p53(+/-) mutant miceAlison M Y Cheung, Andrew Elia, Ming-Sound Tsao, et al.
Cancers|July 2, 2021
Exosomal microRNA in Pancreatic Cancer Diagnosis, Prognosis, and Treatment: From Bench to BedsideMd Hafiz Uddin, Mohammed Najeeb Al-Hallak, Philip A Philip, et al.
Scientific Reports|April 17, 2026
Intestinal epithelial cell-specific deletion of Jak2 disrupts gut homeostasisBrooke D'Mello, Daniel Rivera, Sonia Rehal, et al.
Oncotarget|February 19, 2015
Carboxyl-terminal domain of MUC16 imparts tumorigenic and metastatic functions through nuclear translocation of JAK2 to pancreatic cancer cellsSrustidhar Das, Satyanarayana Rachagani, Maria P Torres-Gonzalez, et al.
Molecular and Cellular Biology|January 29, 2014
Stat5 regulates the phosphatidylinositol 3-kinase/Akt1 pathway during mammary gland development and tumorigenesisJeffrey W Schmidt, Barbara L Wehde, Kazuhito Sakamoto, et al.
Pageof 13

Showing results (61-70 of 124) with videos related to

Sort By:
Pageof 13
The Journal of Biological Chemistry|March 9, 2002
Loss of the peroxisome proliferation-activated receptor gamma (PPARgamma ) does not affect mammary development and propensity for tumor formation but leads to reduced fertilityYongzhi Cui, Keiko Miyoshi, Estefania Claudio, et al.
Biology of Reproduction|January 24, 2002
Bcl-x is not required for maintenance of follicles and corpus luteum in the postnatal mouse ovaryGregory Riedlinger, Ryugo Okagaki, Kay-Uwe Wagner, et al.
The American Journal of Pathology|June 11, 2013
Loss of Jak2 impairs endothelial function by attenuating Raf-1/MEK1/Sp-1 signaling along with altered eNOS activitiesPing Yang, Yawen Zhang, Junfeng Pang, et al.
Molecular Endocrinology (Baltimore, Md.)|June 7, 2007
Coactivation of janus tyrosine kinase (Jak)1 positively modulates prolactin-Jak2 signaling in breast cancer: recruitment of ERK and signal transducer and activator of transcription (Stat)3 and enhancement of Akt and Stat5a/b pathwaysLynn M Neilson, Jianquong Zhu, Jianwu Xie, et al.
Cell Cycle (Georgetown, Tex.)|October 20, 2004
Brca1-deficient murine mammary epithelial cells have increased sensitivity to CDDP and MMSMagdalene K Sgagias, Kay-Uwe Wagner, Brad Hamik, et al.
Cancer Research|March 18, 2004
Brca2 deficiency does not impair mammary epithelium development but promotes mammary adenocarcinoma formation in p53(+/-) mutant miceAlison M Y Cheung, Andrew Elia, Ming-Sound Tsao, et al.
Cancers|July 2, 2021
Exosomal microRNA in Pancreatic Cancer Diagnosis, Prognosis, and Treatment: From Bench to BedsideMd Hafiz Uddin, Mohammed Najeeb Al-Hallak, Philip A Philip, et al.
Scientific Reports|April 17, 2026
Intestinal epithelial cell-specific deletion of Jak2 disrupts gut homeostasisBrooke D'Mello, Daniel Rivera, Sonia Rehal, et al.
Oncotarget|February 19, 2015
Carboxyl-terminal domain of MUC16 imparts tumorigenic and metastatic functions through nuclear translocation of JAK2 to pancreatic cancer cellsSrustidhar Das, Satyanarayana Rachagani, Maria P Torres-Gonzalez, et al.
Molecular and Cellular Biology|January 29, 2014
Stat5 regulates the phosphatidylinositol 3-kinase/Akt1 pathway during mammary gland development and tumorigenesisJeffrey W Schmidt, Barbara L Wehde, Kazuhito Sakamoto, et al.
Pageof 13